Tissue-type plasminogen activator deficiency attenuates peritoneal fibrosis in mice
2009
Peritoneal fibrosis (PF) is an important complication of peritoneal dialysis therapy. The present study was performed to examine the mechanisms of PF in view of the plasminogen activator (PA)/
plasmin/matrix
metalloproteinase(MMP) cascade. PF was induced in
tissue-typePA (tPA) deficient mice and wild-type mice by intraperitoneal injection of
chlorhexidine
gluconate. Mice were killed on day 21, and tissue samples were taken. Histopathological studies were performed.
Plasminactivity,
gelatinasesactivity, and the levels of tPA, transforming growth factor-β1 (TGF-β1), and MMP-2 mRNA were determined. Protein levels of MMP-3,
tissue inhibitorof
metalloproteinases(TIMP)-1, -2, and -3, phospho-Smad3, membrane-type 1 (MT1)-MMP, and MT3-MMP were also studied. On day 21, tPA +/+ mice showed severe PF, whereas tPA −/− mice showed milder change. Submesothelial basement membranes were dissolved in tPA +/+ mice while they were relatively preserved in tPA −/− mice. The levels of macrophage infiltration, staining for...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
-
Machine Reading By IdeaReader
39
References
15
Citations
NaN
KQI